312 related articles for article (PubMed ID: 33118518)
1. [Zoledronate regulates osteoclast differentiation and bone resorption in high glucose through p38 MAPK pathway].
Lin Y; Gu Y; Zuo G; Jia S; Liang Y; Qi M; Dong W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1439-1447. PubMed ID: 33118518
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway.
Dong W; Qi M; Wang Y; Feng X; Liu H
Biochem Biophys Res Commun; 2018 Nov; 505(4):1195-1202. PubMed ID: 30322621
[TBL] [Abstract][Full Text] [Related]
3. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
4. Inhibition Effect of Zoledronate on the Osteoclast Differentiation of RAW264.7 Induced by Titanium Particles.
Zhao W; Huang Z; Lin Y; Lan J; Gao X
Biomed Res Int; 2021; 2021():5578088. PubMed ID: 33763474
[TBL] [Abstract][Full Text] [Related]
5. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
[TBL] [Abstract][Full Text] [Related]
6. Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-κB and MAPK pathways.
Gan K; Yang L; Xu L; Feng X; Zhang Q; Wang F; Tan W; Zhang M
Int Immunopharmacol; 2016 Jun; 35():294-300. PubMed ID: 27085680
[TBL] [Abstract][Full Text] [Related]
7. [Effect of zoledronate on the osteoclast adhesion and gene expression of integrin α(v) and β3].
Jueshan L; Wei D; Chunfeng X; Hong S; Xiaojie F; Mengchun Q
Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Dec; 32(6):547-51. PubMed ID: 25665417
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways.
Huang XL; Liu C; Shi XM; Cheng YT; Zhou Q; Li JP; Liao J
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935053
[TBL] [Abstract][Full Text] [Related]
9. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway.
Chawalitpong S; Sornkaew N; Suksamrarn A; Palaga T
Eur J Pharmacol; 2016 Oct; 788():351-359. PubMed ID: 27523282
[TBL] [Abstract][Full Text] [Related]
10. TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.
Shen Y; Wang Z; Tan J; Zhong J; Chen L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 50(2):162-170. PubMed ID: 34137231
[TBL] [Abstract][Full Text] [Related]
11. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
12. [Zoledronate inhibits TRPV5 and NFATc1 expression during differentiation of osteoclasts].
Lin J; Dong W; Zhang P; Li P; Sun H; Qi M
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1254-8. PubMed ID: 25263354
[TBL] [Abstract][Full Text] [Related]
13. IL13Rα2 as a crucial receptor for Chi3l1 in osteoclast differentiation and bone resorption through the MAPK/AKT pathway.
Xu W; Chao R; Xie X; Mao Y; Chen X; Chen X; Zhang S
Cell Commun Signal; 2024 Jan; 22(1):81. PubMed ID: 38291404
[TBL] [Abstract][Full Text] [Related]
14. Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway.
Ma C; Geng B; Zhang X; Li R; Yang X; Xia Y
Med Sci Monit; 2020 Jan; 26():e918370. PubMed ID: 31914120
[TBL] [Abstract][Full Text] [Related]
15. Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.
Deepak V; Kruger MC; Joubert A; Coetzee M
Biofactors; 2015; 41(6):403-13. PubMed ID: 26627060
[TBL] [Abstract][Full Text] [Related]
16. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
[TBL] [Abstract][Full Text] [Related]
17. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
20. [Icariin inhibits thioacetamide-induced osteoclast differentiation through RANKL-p38/ERK-NFAT pathway].
Cheng LY; Jin XL; Chen XW; Chen J; Ren J; Huang H; Xu J
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5882-5889. PubMed ID: 36472007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
